Inactive Instrument
CEREP Share Price Euronext Paris
Stocks
FR0004042232
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - EUR | - |
|
| 30/04 | Eurofins-Cerep SA Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 02/25/02 | Eurofins-Cerep SA Reports Earnings Results for the Half Year Ended June 30, 2025 | CI |
| Market Cap | 8.68Cr 9.89Cr 8.01Cr 7.4Cr 14Cr 947.11Cr 14Cr 96Cr 37Cr 463.48Cr 37Cr 36Cr 1.61TCr | P/E 2024 * |
-
| P/E 2025 | - |
|---|---|---|---|---|---|
| Enterprise Value | 6.57Cr 7.49Cr 6.07Cr 5.61Cr 11Cr 717.48Cr 11Cr 73Cr 28Cr 351.11Cr 28Cr 28Cr 1.22TCr | EV / Sales 2024 |
2.02x | EV / Sales 2025 | 1.67x |
| Free-Float |
4.22% | Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Damien Vielliard
CEO | Chief Executive Officer | - | 11/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Paul Ratcliffe
CHM | Chairman | - | 11/08/2023 |
Damien Vielliard
BRD | Director/Board Member | - | 23/05/2024 |
Rodolphe Simonot
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.31% | +1.63% | +1.99% | +8.55% | 4.94TCr | |
| -0.36% | +1.21% | +420.77% | +619.10% | 4.03TCr | |
| -2.13% | +0.29% | +23.91% | -6.01% | 3.4TCr | |
| -2.29% | +3.83% | +23.48% | +59.26% | 3.36TCr | |
| -0.79% | +1.32% | +5.78% | +36.42% | 2.68TCr | |
| +3.82% | +3.51% | - | - | 1.72TCr | |
| -2.62% | -2.13% | +64.96% | +125.87% | 1.52TCr | |
| -2.17% | +6.65% | +104.31% | +102.15% | 1.4TCr | |
| +0.36% | -2.75% | +12.63% | +18.09% | 1.34TCr | |
| Average | -0.66% | +1.48% | +82.23% | +120.43% | 2.71TCr | |
| Weighted average by Cap. | -0.70% | +1.54% | +94.59% | +140.02% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 4.05Cr 4.62Cr 3.74Cr 3.45Cr 6.55Cr 442Cr 6.68Cr 45Cr 17Cr 216.3Cr 17Cr 17Cr 750.86Cr | 4.11Cr 4.69Cr 3.79Cr 3.51Cr 6.65Cr 448.67Cr 6.78Cr 46Cr 18Cr 219.56Cr 18Cr 17Cr 762.19Cr |
| Net income | 71.55L 81.57L 66.05L 61.04L 1.16Cr 78Cr 1.18Cr 7.94Cr 3.09Cr 38Cr 3.06Cr 3Cr 132.68Cr | 47.82L 54.53L 44.15L 40.8L 77.33L 52Cr 78.88L 5.31Cr 2.06Cr 26Cr 2.05Cr 2Cr 89Cr |
| Net Debt | -1.73Cr -1.97Cr -1.59Cr -1.47Cr -2.79Cr -188.35Cr -2.85Cr -19Cr -7.44Cr -92Cr -7.39Cr -7.22Cr -319.96Cr | -2.1Cr -2.4Cr -1.94Cr -1.79Cr -3.4Cr -229.63Cr -3.47Cr -23Cr -9.07Cr -112.37Cr -9.01Cr -8.81Cr -390.1Cr |
Employees
-
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
